Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis to construct pharma plant in Turkey

April 2, 2012
Manufacturing and Production Novartis, Turkey, manufacturing

Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …

News

AstraZeneca wins fresh US victory with Seroquel XR

April 2, 2012
Sales and Marketing AZ, AstraZeneca, FDA, Seroquel XR

AstraZeneca is celebrating a US court verdict in its ongoing battle for intellectual property over the extended release version of …

News

Piramal opens ADC plant in Scotland

April 2, 2012
Manufacturing and Production ADC, Abbott, Piramel

India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …

News
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

News
Roche image

Roche raises Illumina bid to $6.7 billion

April 2, 2012
Sales and Marketing

Roche has increased its takeover bid for Illumina, with the offer now valuing the company at $6.7 billion.The firm makes …

News
Teva image

Teva sells Canadian plant to CMO

March 30, 2012
Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing

Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …

News

Amylin dismisses BMS acquisition deal

March 30, 2012
Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly

Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …

News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …

Appointment
NICE image

NICE recommends Xgeva for bone metastasis

March 29, 2012
Sales and Marketing Amgen, NICE, Xgeva, Zytiga, denosumab, prostate cancer

NICE has issued draft guidance recommending Amgen’s Xgeva (denosumab) for certain groups of cancer patients whose disease has spread to …

News

Approval for Affymax and Takeda’s anaemia treatment

March 29, 2012
Sales and Marketing Affymax, Amgen, ESA, Epogen, Takeda, omontys

The first rival treatment to Amgen’s portfolio of anaemia drugs has been approved in the US.Omontys (peginesatide) has been developed …

News
a_mahmoud

Inovio appoints ex-Merck vaccines president Dr Adel Mahmoud

March 29, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Inovio, Merck, vaccines

Inovio Pharmaceuticals has announced that Dr Adel Mahmoud has been appointed to its Board of Directors.  Mahmoud, a global infectious …

Appointment

Prostate cancer drug extends life after chemotherapy

March 29, 2012
Research and Development, Sales and Marketing Astellas, Medivation, Zytiga, prostate cancer

Prostate cancer treatment MDV3100 has been shown to extend life by nearly five months in men with advanced disease who …

News
Psoriasis Facebook image

Janssen to remove its Psoriasis 360 Facebook page

March 28, 2012
Medical Communications Facebook, Janssen, PM Soc, Psoriasis 360

Janssen has decided to take down its award-winning Psoriasis 360 page on Facebook, citing an increasing amount of troublesome comments. …

News

Omnicom Group chooses CAHG as its lead healthcare agency

March 28, 2012
Medical Communications CAHG. TBWA, Omnicom, WorldHealth

The Omnicom Group has chosen its healthcare comms agency CAHG to form a strategic alliance with TBWA\WorldHealth as the company’s …

News
GSK image

GSK settles cancer patent dispute

March 28, 2012
Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …

News

NHS reforms become law

March 28, 2012
Sales and Marketing CCGs, Commissioning Board, Lansley, NHS, PCTs, QIPP, reforms

After 18 months of political wrangling and mass opposition, the government’s reform of the NHS in England has been passed …

News
Amgen picture

Sanofi sets up cholesterol drug showdown with Amgen

March 27, 2012
Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi

Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other.  Both drugs …

News

Pharma manufacturing news in brief

March 27, 2012
Manufacturing and Production Apotex, Ei Inc, Oxford Pharmascience and Bend Research, PharmaForm

Apotex sues FDA, Ei expands its production facilities in North Carolina, plus new developments at PharmaForm, Oxford Pharmascience and Bend …

News
Merck KGaA image

Merck KGaA manufacturing under scrutiny by FDA

March 27, 2012
Manufacturing and Production FDA, Merck KGaA, Rebif, Violations, manufacturing

The US Food and Drug Administration has asked Merck KGaA to undertake a ‘comprehensive and global assessment’ of its manufacturing …

News

Risk register spells out NHS reform risks

March 27, 2012
Sales and Marketing NHS reforms, commissioning, health bill, risk register

A leaked document that assesses problems with the government’s reform of the NHS has been published by the Guardian. The …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026